Search Results - "TRIMARCHI, Hernan"

Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group by Trimarchi, Hernán, Barratt, Jonathan, Cattran, Daniel C, Cook, H Terence, Coppo, Rosanna, Haas, Mark, Liu, Zhi-Hong, Roberts, Ian S D, Yuzawa, Yukio, Zhang, Hong, Feehally, John

“…Since the Oxford Classification of IgA nephropathy (IgAN) was published in 2009, MEST scores have been increasingly used in clinical practice. Further…”
Get more information

A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy by Haas, Mark, Verhave, Jacobien C, Liu, Zhi-Hong, Alpers, Charles E, Barratt, Jonathan, Becker, Jan U, Cattran, Daniel, Cook, H Terence, Coppo, Rosanna, Feehally, John, Pani, Antonello, Perkowska-Ptasinska, Agnieszka, Roberts, Ian S D, Soares, Maria Fernanda, Trimarchi, Hernan, Wang, Suxia, Yuzawa, Yukio, Zhang, Hong, Troyanov, Stéphan, Katafuchi, Ritsuko

“…The Oxford Classification of IgA nephropathy does not account for glomerular crescents. However, studies that reported no independent predictive role of…”
Get full text

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference by Floege, Jürgen, Barbour, Sean J, Cattran, Daniel C, Hogan, Jonathan J, Nachman, Patrick H, Tang, Sydney C W, Wetzels, Jack F M, Cheung, Michael, Wheeler, David C, Winkelmayer, Wolfgang C, Rovin, Brad H

“…The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference…”
Get more information

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference by Rovin, Brad H, Caster, Dawn J, Cattran, Daniel C, Gibson, Keisha L, Hogan, Jonathan J, Moeller, Marcus J, Roccatello, Dario, Cheung, Michael, Wheeler, David C, Winkelmayer, Wolfgang C, Floege, Jürgen

“…In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative brought a diverse panel of experts in glomerular diseases together to…”
Get more information

Targeting APRIL in the Treatment of IgA Nephropathy by Cheung, Chee Kay, Barratt, Jonathan, Carroll, Kevin, Lafayette, Richard A, Liew, Adrian, Suzuki, Yusuke, Tesař, Vladimír, Trimarchi, Hernán, Wong, Muh Geot, Zhang, Hong, Perkovic, Vlado, Rizk, Dana V

Get more information

Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers by Carter, Simon A, Gutman, Talia, Logeman, Charlotte, Cattran, Dan, Lightstone, Liz, Bagga, Arvind, Barbour, Sean J, Barratt, Jonathan, Boletis, John, Caster, Dawn, Coppo, Rosanna, Fervenza, Fernando C, Floege, Jürgen, Hladunewich, Michelle, Hogan, Jonathan J, Kitching, A Richard, Lafayette, Richard A, Malvar, Ana, Radhakrishnan, Jai, Rovin, Brad H, Scholes-Robertson, Nicole, Trimarchi, Hérnan, Zhang, Hong, Azukaitis, Karolis, Cho, Yeoungjee, Viecelli, Andrea K, Dunn, Louese, Harris, David, Johnson, David W, Kerr, Peter G, Laboi, Paul, Ryan, Jessica, Shen, Jenny I, Ruiz, Lorena, Wang, Angela Yee-Moon, Lee, Achilles Hoi Kan, Fung, Samuel, Tong, Matthew Ka-Hang, Teixeira-Pinto, Armando, Wilkie, Martin, Alexander, Stephen I, Craig, Jonathan C, Tong, Allison

“…Shared decision making in patients with glomerular disease remains challenging because outcomes important to patients remain largely unknown. We aimed to…”
Get full text

Renal Transplantation in Patients Older Than 60 Years With High Comorbidity. Is There a Survival Benefit? A Multicenter Study in Argentina by Fragale, Guillermo Daniel, Pujol, Gervasio Soler, Laham, Gustavo, Raffaele, Pablo, Fortunato, Marcela, Imperiali, Nora, Giordani, María C, Taylor, Marcelo, Ciappa, Julio, Matamala, Natalia, Maldonado, Rafael, Trimarchi, Hernán, Pomeranz, Vanesa, Naser, Sofia, De La Fuente, Jorge, Bisigniano, Liliana, Antik, Ariel

“…The impact of renal transplantation (RT) in the elderly with many comorbid conditions is a matter of concern. The aim of our study was to assess the impact of…”
Get full text

Crescents in primary glomerulonephritis: a pattern of injury with dissimilar actors. A pathophysiologic perspective by Trimarchi, Hernán

“…Cellular crescents are defined as two or more layers of proliferating cells in Bowman’s space and are a hallmark of inflammatory active glomerulonephritis and…”
Get full text

Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease by Carter, Simon A, Logeman, Charlotte, Howell, Martin, Cattran, Dan, Lightstone, Liz, Bagga, Arvind, Barbour, Sean J, Barratt, Jonathan, Boletis, John, Caster, Dawn J, Coppo, Rosanna, Fervenza, Fernando C, Floege, Jürgen, Hladunewich, Michelle A, Hogan, Jonathan J, Kitching, A Richard, Lafayette, Richard A, Malvar, Ana, Radhakrishnan, Jai, Rovin, Brad H, Scholes-Robertson, Nicole, Trimarchi, Hérnan, Zhang, Hong, Cho, Yeoungjee, Dunn, Louese, Gipson, Debbie S, Liew, Adrian, Sautenet, Benedicte, Viecelli, Andrea K, Harris, David, Johnson, David W, Wang, Angela Yee-Moon, Teixeira-Pinto, Armando, Alexander, Stephen I, Martin, Adam, Tong, Allison, Craig, Jonathan C

“…Outcomes relevant to treatment decision-making are inconsistently reported in trials involving glomerular disease. Here, we sought to establish a…”
Get more information

External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian Cohort by Zhang, Yuemiao, Guo, Ling, Wang, Zi, Wang, Jinwei, Er, Lee, Barbour, Sean J., Trimarchi, Hernan, Lv, Jicheng, Zhang, Hong

“…Two prediction models for IgA nephropathy (IgAN) using clinical variables and the Oxford MEST scores were developed and validated in 2 multiethnic cohorts…”
Get full text

Glomerular endothelial activation, C4d deposits and microangiopathy in immunoglobulin A nephropathy by Trimarchi, Hernán, Coppo, Rosanna

“…Abstract Immunoglobulin A nephropathy (IgAN) is considered as mesangiopathy since it initiates in the mesangium; however, other glomerular components are…”
Get full text

Podocytopathy in the mesangial proliferative immunoglobulin A nephropathy: new insights into the mechanisms of damage and progression by Trimarchi, Hernán, Coppo, Rosanna

“…Immunoglobulin A nephropathy (IgAN) was defined as a mesangiopathic disease, since the primary site of deposition of IgA immune material is the mesangium, and…”
Get full text

SARS-CoV-2 and Fabry nephropathy: potential risks and the pathophysiological perspective by Trimarchi, Hernán

“…Fabry disease is an X-linked disorder due to mutations in alpha-galactosidase A gene. It affects the kidney in virtually all patients with classical and some…”
Get full text

The implications of focal segmental glomerulosclerosis in children with IgA nephropathy by Trimarchi, Hernán, Coppo, Rosanna

“…Focal segmental glomerular sclerotic lesions in IgA nephropathy (IgAN), considered for years a chronic histologic feature related to proteinuria in remnant…”
Get full text

Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial by Lafayette, Richard, Kristensen, Jens, Stone, Andrew, Floege, Jürgen, Tesař, Vladimir, Trimarchi, Hernán, Zhang, Hong, Eren, Necmi, Paliege, Alexander, Reich, Heather N, Rovin, Brad H, Barratt, Jonathan

“…IgA nephropathy is a chronic immune-mediated kidney disease and a major cause of kidney failure worldwide. The gut mucosal immune system is implicated in its…”
Get full text

COVID-19 and acute kidney injury in pediatric subjects: is there a place for eculizumab treatment? by Trimarchi, Hernán, Coppo, Rosanna

Get full text

Mechanisms of Podocyte Detachment, Podocyturia, and Risk of Progression of Glomerulopathies by Trimarchi, Hernán

“…Background: Glomerulopathies are the main cause of ESRD. Primary or secondary causes of glomerular diseases comprise more than 70% of cases that end up in…”
Get full text

Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy by Zhang, Hong, Rizk, Dana V, Perkovic, Vlado, Maes, Bart, Kashihara, Naoki, Rovin, Brad, Trimarchi, Hernán, Sprangers, Ben, Meier, Matthias, Kollins, Dmitrij, Papachristofi, Olympia, Milojevic, Julie, Junge, Guido, Nidamarthy, Prasanna Kumar, Charney, Alan, Barratt, Jonathan

“…Targeting the alternative complement pathway is an attractive therapeutic strategy given its role in the pathogenesis of immunoglobulin A nephropathy (IgAN)…”
Get more information

IgA nephropathy: "State of the art": a report from the 15th International Symposium on IgA Nephropathy celebrating the 50th anniversary of its first description by Trimarchi, Hernán, Barratt, Jonathan, Monteiro, Renato C, Feehally, John

“…On September 27-29, 2018, the International Symposium on IgA Nephropathy, organized by the International IgA Nephropathy Network, was held in Buenos Aires,…”
Get more information

Pro-calcitonin and inflammation in chronic hemodialysis by Trimarchi, Hernán, Dicugno, Mariana, Muryan, Alexis, Lombi, Fernando, Iturbe, Leticia, Raña, María S, Young, Pablo, Nau, Karin, Iriarte, Romina, Pomeranz, Vanesa, Forrester, Mariano, Karl, Alejandra, Alonso, Mirta

“…Procalcitonin (PCT) has emerged as a marker of infection, a frequent complication in hemodialysis (HD). We analyzed PCT levels in chronic non-acutely infected…”
Get full text